Dura mater guidance
This article was originally published in The Gray Sheet
Executive Summary
Comments are due Jan. 12, 2000 on the agency's draft "Guidance for the Preparation of a Premarket Notification Application for Processed Human Dura Mater," one of several special controls cited by the Neurological Devices Panel in its Sept. 16 recommendation to classify processed human dura mater as a Class II device (1"The Gray Sheet," Sept. 20, p. 6). Last revised in August, the document addresses product characterization, specifications, manufacturing controls, and labeling issues
You may also be interested in...
Panel Recommends Human Dura Mater Reclassification Into Class II
Processed human dura mater should be classified as a Class II device, FDA's Neurological Devices Panel unanimously (7-0) recommended Sept. 17 at a meeting in Gaithersburg, Maryland.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.